What you need to know about the coronavirus right now
Here’s what you need to know about the coronavirus right now.
Bristol-Myers, Eisai in up to $3.1 bln deal to develop cancer drug candidate
Bristol-Myers Squibb Co (BMY.N) and Eisai Co said on Thursday they had entered into an agreement worth up to $3.10 billion to jointly develop and market an experimental cancer drug.
Lufthansa to allow check-in with digital vaccine pass
Lufthansa (LHAG.DE) will allow passengers to use new digital COVID-19 vaccination certificates at check-in for their flights, the German airline said on Thursday.
What you need to know about the coronavirus right now
Here’s what you need to know about the coronavirus right now.
What you need to know about the coronavirus right now
Here’s what you need to know about the coronavirus right now.
What you need to know about the coronavirus right now
Here’s what you need to know about the coronavirus right now.
U.S. to donate 500 million Pfizer doses to poor nations
The United States will spend $3.5 billion to buy and donate 500 million doses of the Pfizer (PFE.N) coronavirus vaccine to some of the world’s poorest countries, it said on Thursday, urging other G7 nations to follow suit.
What you need to know about the coronavirus right now
Here’s what you need to know about the coronavirus right now.
U.S. approval of Biogen Alzheimer’s drug sends shares soaring, hailed as ‘big day” for patients
U.S. regulators on Monday approved Biogen Inc’s (BIIB.O) aducanumab as the first treatment to attack a likely cause of Alzheimer’s disease despite controversy over whether the clinical evidence proves the drug works, sending its shares soaring.
AstraZeneca moves finance chief to new role after Alexion deal
AstraZeneca (AZN.L) will move finance chief Marc Dunoyer to head newly acquired rare diseases business Alexion (ALXN.O), using the $39 billion takeover as an opportunity to freshen up a management team that had been in place for eight years.
